Mutations disrupting the kinase domain of IKKα lead to immunodeficiency and immune dysregulation in humans.
Riller Q,Sorin B,Courteille C,Ho-Nhat D,Le Voyer T,Debray J,Stolzenberg M,Schmutz M,Pellé O,Becquard T,Rodrigo Riestra M,Berteloot L,Migaud M,Delage L,Jeanpierre M,Boussard C,Brunaud C,Magérus A,Bretot C,Michel V,Roux C,Picard C,Masson C,Bole-Feysot C,Cagnard N,Corneau A,Meyts I,Baud V,Casanova J,Fischer A,Dejardin E,Puel A,Boulanger C,Neven B,Rieux-Laucat F
Source :
2025 Jan 16
Pmid / DOI:
39812688
Abstract
IKKα, encoded by CHUK, is crucial in the non-canonical NF-κB pathway and part of the IKK complex activating the canonical pathway alongside IKKβ. The absence of IKKα causes fetal encasement syndrome in humans, fatal in utero, while an impaired IKKα-NIK interaction was reported in a single patient and causes combined immunodeficiency. Here, we describe compound heterozygous variants in the kinase domain of IKKα in a female patient with hypogammaglobulinemia, recurrent lung infections, and Hay-Wells syndrome-like features. We showed that both variants were loss-of-function. Non-canonical NF-κB activation was profoundly diminished in stromal and immune cells while the canonical pathway was unexpectedly partially impaired. Reintroducing wt CHUK restored non-canonical NF-κB activation. The patient had neutralizing autoantibodies against type I IFN, akin to non-canonical NF-κB pathway deficiencies. Thus, this is the first case of biallelic CHUK mutations disrupting IKKα kinase function, broadening non-canonical NF-κB defect understanding, and suggesting IKKα's role in canonical NF-κB target gene expression in humans.© 2025 Riller et al.